The relationship between family medical history and childhood vitiligo.

[1]  R. Spritz,et al.  Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. , 2005, Pigment cell research.

[2]  G. Chrousos,et al.  Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. , 2005, Journal of the American Academy of Dermatology.

[3]  Jean-Paul Ortonne,et al.  Melanin pigmentary disorders: treatment update. , 2005, Dermatologic clinics.

[4]  B. Lie,et al.  CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. , 2005, Pigment cell research.

[5]  T. Tüting,et al.  Peripheral CD8+ T cell tolerance against melanocytic self-antigens in the skin is regulated in two steps by CD4+ T cells and local inflammation: implications for the pathophysiology of vitiligo. , 2005, The Journal of investigative dermatology.

[6]  J. Yamamoto-Furusho,et al.  HLA-DRB1 *04 is associated with the genetic susceptibility to develop vitiligo in Mexican patients with autoimmune thyroid disease. , 2005, Journal of the American Academy of Dermatology.

[7]  J. Sinagra,et al.  Relevance of Thyroiditis and of Other Autoimmune Diseases in Children with Vitiligo , 2004, Dermatology.

[8]  A. Paller,et al.  Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. , 2004, Journal of the American Academy of Dermatology.

[9]  Xuejun Zhang,et al.  Characteristics of genetic epidemiology and genetic models for vitiligo. , 2004, Journal of the American Academy of Dermatology.

[10]  P. Grimes.  White patches and bruised souls: advances in the pathogenesis and treatment of vitiligo. , 2004, Journal of the American Academy of Dermatology.

[11]  A. Akar,et al.  Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. , 2004, Pigment cell research.

[12]  R. Spritz,et al.  A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. , 2003, American journal of human genetics.

[13]  R. Spritz,et al.  Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. , 2003, Pigment cell research.

[14]  S. Dogra,et al.  Epidemiology of Childhood Vitiligo: A Study of 625 Patients from North India , 2003, Pediatric dermatology.

[15]  B. Moncada,et al.  A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. , 2003, Archives of Dermatology.

[16]  Soyun Cho,et al.  Characteristics of Vitiligo in Korean Children , 2000, Pediatric dermatology.

[17]  Legg,et al.  Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology , 1998, Clinical and experimental dermatology.

[18]  M. Westhofen,et al.  Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. , 1994, Dermatology.

[19]  P. Majumder,et al.  Pattern of familial aggregation of vitiligo. , 1993, Archives of dermatology.

[20]  H. Tagami,et al.  Therapeutic success of epidermal grafting in generalized vitiligo is limited by the Koebner phenomenon. , 1990, Journal of the American Academy of Dermatology.

[21]  R. Sweet.  Vitiligo as a Köbner phenomenon , 1978, The British journal of dermatology.